CD14, CD14 molecule, 929

N. diseases: 551; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 GeneticVariation group BEFREE Association of CD14 gene -260 C>T and -561 C>T polymorphisms with cancer susceptibility: a meta-analysis. 31826310 2020
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 Biomarker group BEFREE Danger matrix molecules orchestrate CD14/CD44 signaling in cancer development. 31412297 2020
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 Biomarker group BEFREE BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target? 30235890 2018
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 Biomarker group BEFREE A significant association was also observed between NFKB1 and CD14 variants and the evolution of the lesions; interestingly, this association was with both progression and regression in the same direction, which could reflect the dual role of inflammation in cancer. 30171605 2018
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 AlteredExpression group BEFREE CD14 expression in this BC subpopulation of cancer cells is required for increased cytokine production and increased tumor growth. 25825750 2015
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 GeneticVariation group BEFREE Overall, no significant associations between the two polymorphisms of CD14 gene and cancer risk were found. 24978812 2014
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 Biomarker group BEFREE The cancer cell migration rate in Matrigel was measured by imaging fluorescently stained cells for 24 h. After invasion, cells were sorted into CD14 positive/negative macrophages and cancer cells with magnetic separation. 24526468 2014
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.080 Biomarker group BEFREE We suggest that Wnt5a is a possible candidate mediator for the CD14⁺/⁺⁺ CD16⁺ monocyte accumulation seen in patients with infectious disease and cancer. 23679576 2013